Viking Therapeutics (VKTX) Change in Account Payables (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Change in Account Payables came in at $1.8 million in Q2 2026, up 182.84% year-over-year from $647002.2 in Q2 2025, and down 86.86% quarter-over-quarter from $13.9 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Change in Account Payables (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Change in Account Payables across 13 years of filings, most recently posting $1.8 million for Q2 2026.
- In Q2 2026, Change in Account Payables rose 182.84% year-over-year to $1.8 million; the TTM figure through Jun 2026 stood at $63.5 million (up 1235.67% YoY), while the FY2025 annual figure was $43.4 million, up 1786.15% from the prior year.
- Change in Account Payables came in at $1.8 million for Q2 2026 at Viking Therapeutics, down from $13.9 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $48.8 million in Q4 2025 to a low of -$10.8 million in Q3 2024.
- Average Change in Account Payables over 5 years is $3.8 million, with a median of $1.8 million recorded in 2022.
- Year-over-year, Change in Account Payables tumbled 10935.0% in 2024 and jumped 760.24% in 2026.
- Over 5 years, Change in Account Payables stood at $5.4 million in 2022, then slumped by 66.57% to $1.8 million in 2023, then surged by 430.87% to $9.6 million in 2024, then soared by 410.8% to $48.8 million in 2025, then plunged by 96.25% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $1.8 million in Q2 2026, $13.9 million in Q1 2026, and $48.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -70.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 18.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | -66.70 Mn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 1.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Mar 31, 2026 | 13.93 Mn |
| Dec 31, 2025 | 48.84 Mn |
| Sep 30, 2025 | -1.08 Mn |
| Jun 30, 2025 | -2.21 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Sep 30, 2024 | -10.84 Mn |
| Jun 30, 2024 | 5.86 Mn |
| Mar 31, 2024 | -2.29 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | -4.73 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | -2.96 Mn |
| Jun 30, 2022 | 2.95 Mn |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | -1.39 Mn |
| Sep 30, 2021 | -1.38 Mn |
API Access
Viking Therapeutics Change in Account Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-account-payables", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();